↓ Skip to main content

Navitoclax enhances the effectiveness of EGFR-targeted antibody-drug conjugates in PDX models of EGFR-expressing triple-negative breast cancer

Overview of attention for article published in Breast Cancer Research, November 2020
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
30 Mendeley